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CASE REPORT

ABSTRACT

Treatment of a Rare Vascular Complication
of Coronary Stenting in an Octagenarian
Hunaina Shahab, Bilal Hussain, Nasir Rahman and Fateh Ali Tipoo Sultan

The ability of drug-eluting stent (DES) to inhibit intimal proliferation has resulted in a massive increase in their usage over
the years. However, it is known that the application of DES can alter the normal cascade of vascular healing, resulting in
delayed endothelialisation with risk of vascular complications. Coronary artery aneurysms (CAN) are defined as more than
50% dilatation of the coronary artery compared to the reference vessel diameter with the reported incidence after
percutaneous intervention (PCI) being only around 0.35 to 6.0%. Previously, CAN had been reported with the use of bare
metal stent secondary to stretch, stent fracture and dissection. However, recently, increasing number of cases have been
reported describing CAN after DES implantation. To the best of the authors' knowledge, they present the first case from
Pakistan of a left anterior descending coronary artery aneurysm after DES implantation treated successfully with stenting
under intravascular ultrasound guidance.
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INTRODUCTION

Coronary artery aneurysms (CAN) are defined as more
than 50% dilatation of coronary arteries compared to
reference vessels diameter,1 with incidence of 0.35 to
6.0%.2,3 Previously, CAN had been reported with bare
metal stents (BMS) secondary to stretch, stent fracture
and dissection.2 Recently, increasing number of cases
report CAN after drug-eluting stent (DES) implantation.4,5
To the best of the authors' knowledge, the first case
presented from Pakistan of a left anterior descending
(LAD) CAN after DES implantation treated successfully
with stenting.

CASE REPORT

with mild-moderate aortic stenosis and moderate mitral
regurgitation.

She underwent a left heart catheterisation via right femoral
artery 6F sheath (Cordis®). Left coronary system was
visualised using JL4 6F` catheter showing short left main
vessel bifurcating into LAD and left circumflex vessels
(LCx). LAD had tight in-stent re-stenosis (ISR) in the
proximal part of previous stent (Cypher 2.5x23 mm),
followed by CAN (Figures 1A and 1B). LCx had mild
plaquing. Right coronary artery was engaged using JR4
6F` diagnostic catheter, showing mild plaquing.
The left main artery was engaged with VL3 (Cordis®)
guiding catheter and LAD wired with BMW (Abbott®)

An 85-year lady with a history of percutaneous
intervention (PCI) to left anterior descending LAD with
CypherTM stent (DES) in 2007, presented to the
Emergency Department of The Aga Khan University
Hospital with increasing restlessness and cough. She
had a pulse of 110 beats/minute, respiratory rate of 40
breaths/minute and blood pressure of 90/60 mmHg. She
had bibasilar crepitations on auscultation and troponin-I
of 10.5 ng/ml. Her electrocardiogram (ECG) showed old
left bundle branch block. Transthoracic echocardiogram
showed an estimated ejection fraction of 25-30%
with akinetic apex, septum, mid anterior segments along
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Figure 1: (A, B): Coronary angiogram showing tight in stent re-stenosis (ISR)
in Left Anterior Descending (LAD) stent, followed by coronary artery
aneurysm in the prior stent. (C, D) Angiogram after stenting of prior mid Left
Anterior Descending (LAD) stent and coronary aneurysm. Post PCI TIMI III
flow was achieved in LAD.
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Figure 2: (A) Intravascular ultrasound (IVUS) showing ISR along with
aneurysm in prior mid Left Anterior Descending (LAD) stent. (B) Well
deployed and apposed stent with minimal gap in between two stent struts
visualised.

0.014 inch wire. Mid-LAD ISR was predilated with
Saphire II (OrbusneichTM) 2.0x10 mm at 6 atm (Figures
1C and 1D). Intravascular ultrasound (IVUS) revealed
ISR in proximal part of mid-LAD stent with aneurysm
(Figure 2A). Xience xpedition (Abbott®) 2.5x33 mm
(DES) was deployed into mid-LAD stent including
proximal and distal segments to it at 10 atm. Stent was
post-dilated sequentially with NC TREK (Abbott®)
2.5x15 mm at 14-20 atm and NC TREK (Abbott®) 3.0x8
mm at 10-16 atm. At the end of procedure, IVUS
revealed well-deployed and apposed stent with minimal
gap in between two stent struts (Figure 2B). TIMI-III flow
was achieved in LAD.
The patient was kept on dual antiplatelets (DAPT) and
glycoprotein IIb/IIIa inhibitor (GpIIb/IIIa) infusion. She
improved over the course of admission.

DISCUSSION

DES are impregnated with drugs which interfere with
inflammatory pathways and neo-intimal proliferation,
however, these local effects induce delayed reendothelialisation, hypersensitivity reactions, and
inflammatory changes of vessel wall, leading to CAN
formation.6,7 Coronary angiography is gold standard
for diagnosing CAN, yet it only gives information
regarding lumen of the arteries.2 IVUS allows detailed
characterisation of the aneurysms, as it visualises layers
of the coronary arteries and differentiates between true
and pseudo-aneurysms.8 Aoki et al. have classified CAN
into 3 types.2 Type-1 occurs within 1 month secondary to
mechanical injury to the arterial wall. Type-2 occurs after
6 months of stent placement as an arterial wall response
to DES. Type-3 are infectious mycotic aneurysms.
There are no documented guidelines for management of
stent-related CAN. The only available data are isolated
management protocols from individual case reports.
These include observation, antiplatelet treatment, coiling
or surgical excision.9 Aoki et al proposed a management
plan.2 They suggest percutaneous treatment with stent
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graft, bavemetel stent (BMS) or surgery for large (more
than 2 times the size of reference vessel) or symptomatic
pseudo-aneurysms and large and/or symptomatic true
aneurysms. For small or asymptomatic true and
pseudoaneurysms, followup angiography at 3 to 6
months is suggested. For small true aneurysms and
those large asymptomatic with no change in follow-up
angiography, careful observation and DAPT is
suggested. We used IVUS, as it aptly detects malapposition of DES and vessel wall and also defines the
size of aneurysms especially in cases of DES
thrombosis.10 There is a lack of guidelines on the choice
of antiplatelet therapy and duration of antiplatelets in
cases of CAN. We decided to keep our patient post-PCI
on DAPT and GpIIb/IIIa infusion for optimal antiplatelet
effect.
CANs are rare vascular complications of DES. Their
optimum treatment is still debatable, yet the application
of DES under IVUS guidance can result in successful
treatment.
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